The finding that aTGFβ1 impairs invasive activities induced by exogenous/rhTGFβ1 suggests an anti-oncogenic function in late-stage carcinomas when malignant progression is largely driven by high concentrations of stromal cell-derived TGFβ1 in the tumor microenvironment. Here, TGFB1 is linked to carcinoma.